GO NEWS DAILY

J&K Bank profit jumps 36% as asset quality and growth improve


Jammu & Kashmir Bank reported a 36% surge in fourth quarter net profit at Rs 798 crore against Rs Rs 585 crore in the year ago period, while asset quality improved.

Operating profit stood higher at Rs 911 crore against Rs 800 crore.

J&K Bank posted its highest ever annual profit of Rs 2364 crore in FY26, registering a 13% rise over Rs 2083 crore reported for FY25.

Its gross non-performing assets ratio fell to 2.5% at the end of March from 3% three months prior.

Its net advances expanded 18% year-on-year to Rs 123 lakh crore while deposits rose 11.30% to Rs 1.65 lakh crore.

Live Events


“Going forward, we remain focused on leveraging emerging opportunities across geographies in the rest of the country while deepening our presence in core markets of J&K and Ladakh,” managing director Amitava Chatterjee said.

“The strategic thrust continues to be on expanding retail lending, supporting MSMEs and enhancing credit flow to the agriculture sector”, he added.

Spandana Sphoorty Financial posts Rs 5.3 crore Q4 profit

Microfinance lender Spandana Sphoorty Financial has earned Rs 5.3 crore consolidated net profit for the fourth quarter of the last fiscal, marking its return to black after consecutive six quarters of making net losses.

The Kedaara Capital-backed lender had made a 95 crore consolidated net loss in the third quarter while the net loss stood at Rs 434 crore in the March quarter last year.

Gross profit was at Rs 8 crore as compared with Rs 126 crore loss in the preceding quarter and Rs 578 crore loss in the year ago period.

The lender’s consolidated annual net loss stood at Rs 699 crore in FY26 against Rs 1035 crore loss in FY25.

The group’s assets under management grew 12% quarter-on-quarter to Rs 4420 crore at the end of March after a prolonged decline amid the asset quality stress that the microfinance sector was subjected to.

Spandana’s gross non-performing assets ratio on a consolidated basis stood at 3.78% at the end of March, coming down from 4.24% three months prior. Stanadalone gross NPA ratio however rose to 3..3% from 2.6% over the same period.



Source link

Exit mobile version